about
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationCharacterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status.Angiogenesis in head and neck squamous cell carcinoma.Markers for the lymphatic endothelium: in search of the holy grail?VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinomaSerum biomarkers VEGF-C and IL-6 are associated with severe human Peripheral Artery Stenosis.The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.High-mobility group box 1 protein activating nuclear factor-κB to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer.VEGF-C promotes survival in podocytes.Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues.
P2860
08dd0fe1d209e094a9dfe188686d9d10151db6f6705892f13ef7e6554ef15864f9d7414f7d98509398468888cccf69431184cb24776cb91b825b8016bc513800917dc86ab3aa92fa36a00ecb1f8e58ffbf549b3276488b9b3232f9dd198850dd8821b647cd6c688d34ce02fe3400f062fae9459845198fd4cdd667313a6cb0d71238271c7b36f29c37b85303d584fe263555d90df0b81d0719e983658574dcd0d9ce272c437e05627681c836a2950a6b7c2c784ceab11c1ff823ecb8ae84148503675e699c28856b
P248
Q24675931-496DE486-ABDA-49D6-9488-6D61A3E2AA88Q28580820-3CBCCCE6-AEF7-4622-B837-F8816C8B0BECQ33569726-5DC13B22-A94B-4365-A3ED-4DF5C8D86E17Q34004670-2DEB0540-B5B6-4E6A-8BEA-50A2B84FE600Q34398711-E133011B-EF5B-472A-8273-6C8085A8D6A8Q35087391-DB69821A-A823-4DDE-8510-742429069211Q35961712-F35FD2A7-FDA5-493C-A475-AE2D69CC22C9Q36589860-78DF9092-2252-45FD-8E5C-65F6F5A799F5Q37997765-E7CF9075-9CCD-40A3-965B-CCF84400993DQ38386206-37B653FA-9608-4B1B-A3F4-CCB2D1F6C85EQ40307403-48899CCB-59FD-4E25-8F56-56425DFCB21EQ47341098-EB8C3D9A-4B37-417D-9D56-03925C7C567B
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Characterization of murine Flt4 ligand/VEGF-C
@ast
Characterization of murine Flt4 ligand/VEGF-C
@en
Characterization of murine Flt4 ligand/VEGF-C
@nl
type
label
Characterization of murine Flt4 ligand/VEGF-C
@ast
Characterization of murine Flt4 ligand/VEGF-C
@en
Characterization of murine Flt4 ligand/VEGF-C
@nl
prefLabel
Characterization of murine Flt4 ligand/VEGF-C
@ast
Characterization of murine Flt4 ligand/VEGF-C
@en
Characterization of murine Flt4 ligand/VEGF-C
@nl
P2093
P356
P1433
P1476
Characterization of murine Flt4 ligand/VEGF-C
@en
P2093
A Ciarletta
E Nickbarg
H Finnerty
J C Morris
J Giannotti
K J Turner
P2888
P356
10.1038/SJ.ONC.1201191
P407
P577
1997-07-31T00:00:00Z
P6179
1012009134